InvestorsHub Logo
Followers 523
Posts 6631
Boards Moderated 1
Alias Born 07/24/2012

Re: None

Wednesday, 10/31/2012 1:06:50 PM

Wednesday, October 31, 2012 1:06:50 PM

Post# of 130503
Amarantus BioSciences Provides Update to Shareholders
SUNNYVALE, Calif. – October 10, 2012
As new and exciting proof-of-concept data for MANF in secondary therapeutic indications continues to be published by research laboratories throughout Europe, China, Japan and North America, the value of our intellectual property (“IP”) portfolio is steadily increasing. We are continually expanding our IP portfolio for MANF by filing and aggregating new patents